Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases

WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company’s existing repurchase authorization, of which $1 billion was remaining.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241115656946/en/

Media Contact Information:
Sandy Pound
781-622-1223
[email protected]

Investor Contact Information:
Rafael Tejada
781-622-1356
[email protected]

Source: Thermo Fisher Scientific Inc.

You May Also Be Interested In

• Curtiss-Wright Announces New $100 Million Expansion of 2026 Share Repurchase Program
• Rosalie Morton, SVP at Padilla, Named to Ragan’s Top Women in Marketing, Class of 2026
• Offerpad Announces Transfer of Stock Exchange Listing to Nasdaq